Biosimilars & Biologics

Description :

Biosimilars and Biologic medicines are large, complex molecules that are made in living cells which is grown in a laboratory. Biologic medicines are often 200 to 1,000 times the size of a small molecule or chemical drug such as aspirin. Due to both their large molecular size and fragile molecular structure, biologic medicines are almost always injected into the patient’s body.

Related: Biosimilars Conferences | Biosimilars Conferences 2020 | Biosimilars Congress | Biosimilars Congress 2020 | Biosimilars Meetings | Biosimilars Meetings 2020| Biosimilars Events | Biosimilars Events 2020 | Biologics Conferences | Biologics Conferences 2020 | Biologics Congress | Biologics Congress 2020 | Biologics Meetings | Biologics Meetings 2020| Biologics Events | Biologics Events 2020

AI in Drug Discovery Conference 2020; 3rd Annual Pharma Supply Chain & Security World 2020 - Supply-Chain, Drug Serialization and Anti-Counterfeiting Conference 2020; International Society For Pharmaceutical Engineering Europe Annual Conference 2020; Americas World Drug Safety Congress 2020.

Related Associations: Pharmaceutical Society of Australian Capital Territory branch; Association for Accessible Medicines; Association of the British Pharmaceutical Industry; Bio Process Systems Alliance; British Generic Manufacturers Association; Bundesverband der Pharmazeutischen Industry; Company Chemists’ Association